SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-024766
Filing Date
2015-04-24
Accepted
2015-04-24 08:30:21
Documents
10
Period of Report
2015-06-03
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A v407629_def14a.htm DEF 14A 350289
2 GRAPHIC tlogo.jpg GRAPHIC 7659
3 GRAPHIC tpg1notice.jpg GRAPHIC 119278
4 GRAPHIC tpg2notice.jpg GRAPHIC 199309
5 GRAPHIC tpg3notice.jpg GRAPHIC 65681
6 GRAPHIC tpg4notice.jpg GRAPHIC 14957
7 GRAPHIC tpg1proxy.jpg GRAPHIC 204391
8 GRAPHIC tpg2proxy.jpg GRAPHIC 186478
9 GRAPHIC sig_charlotte-arnold.jpg GRAPHIC 1935
10 GRAPHIC sig_arthur-przybyl.jpg GRAPHIC 5344
  Complete submission text file 0001144204-15-024766.txt   1461980
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 15790030
SIC: 2834 Pharmaceutical Preparations